[go: up one dir, main page]

FR2781159B1 - Vaccin circovirus et parvovirus porcin - Google Patents

Vaccin circovirus et parvovirus porcin

Info

Publication number
FR2781159B1
FR2781159B1 FR9808777A FR9808777A FR2781159B1 FR 2781159 B1 FR2781159 B1 FR 2781159B1 FR 9808777 A FR9808777 A FR 9808777A FR 9808777 A FR9808777 A FR 9808777A FR 2781159 B1 FR2781159 B1 FR 2781159B1
Authority
FR
France
Prior art keywords
circovirus vaccine
porcine
pig parvovirus
parvovirus
circovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9808777A
Other languages
English (en)
Other versions
FR2781159A1 (fr
Inventor
Gordon Allan
Brian Meehan
John Ellis
George Steven Krakowka
Jean Christophe Franc Audonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial SAS
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9808777A priority Critical patent/FR2781159B1/fr
Application filed by Merial SAS, Merial Inc filed Critical Merial SAS
Priority to PCT/EP1999/004698 priority patent/WO2000001409A2/fr
Priority to PL345948A priority patent/PL205299B1/pl
Priority to KR1020017000182A priority patent/KR100730336B1/ko
Priority to AT99932831T priority patent/ATE452653T1/de
Priority to HU0102770A priority patent/HU227805B1/hu
Priority to AU49077/99A priority patent/AU746234B2/en
Priority to BRPI9911870A priority patent/BRPI9911870B8/pt
Priority to ES99932831T priority patent/ES2338616T3/es
Priority to UA2001020808A priority patent/UA72891C2/xx
Priority to CA2332627A priority patent/CA2332627C/fr
Priority to DE69941843T priority patent/DE69941843D1/de
Priority to PT99932831T priority patent/PT1094837E/pt
Priority to EP99932831A priority patent/EP1094837B1/fr
Priority to DK99932831.3T priority patent/DK1094837T3/da
Priority to MXPA00012785A priority patent/MXPA00012785A/es
Priority to CNB998091316A priority patent/CN1168502C/zh
Priority to JP2000557855A priority patent/JP4749547B2/ja
Priority to RU2001103135A priority patent/RU2237492C2/ru
Priority to US09/347,594 priority patent/US6217883B1/en
Publication of FR2781159A1 publication Critical patent/FR2781159A1/fr
Priority to TW088111464A priority patent/TWI221774B/zh
Application granted granted Critical
Publication of FR2781159B1 publication Critical patent/FR2781159B1/fr
Priority to US09/784,962 priority patent/US6953581B2/en
Priority to US10/653,849 priority patent/US7192594B2/en
Priority to US11/107,219 priority patent/US20060029617A1/en
Priority to US11/217,562 priority patent/US7504206B2/en
Priority to US11/485,525 priority patent/US7803613B2/en
Priority to US11/485,240 priority patent/US7833783B2/en
Priority to US11/522,237 priority patent/US7803926B2/en
Priority to CY20101100181T priority patent/CY1110290T1/el
Priority to JP2010100018A priority patent/JP2010222359A/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR9808777A 1997-10-03 1998-07-06 Vaccin circovirus et parvovirus porcin Expired - Lifetime FR2781159B1 (fr)

Priority Applications (30)

Application Number Priority Date Filing Date Title
FR9808777A FR2781159B1 (fr) 1998-07-06 1998-07-06 Vaccin circovirus et parvovirus porcin
JP2000557855A JP4749547B2 (ja) 1998-07-06 1999-06-28 ブタサーコウイルスおよびパルボウイルスワクチン
KR1020017000182A KR100730336B1 (ko) 1998-07-06 1999-06-28 돼지 써코바이러스 및 파보바이러스 백신
AT99932831T ATE452653T1 (de) 1998-07-06 1999-06-28 Schweine-circovirus und -parvovirus impfstoff
HU0102770A HU227805B1 (en) 1998-07-06 1999-06-28 Porcine circovirus and parvovirus vaccine
AU49077/99A AU746234B2 (en) 1998-07-06 1999-06-28 Porcine circovirus and parvovirus vaccine
BRPI9911870A BRPI9911870B8 (pt) 1998-07-06 1999-06-28 vacina de parvovírus e circovírus de suíno
ES99932831T ES2338616T3 (es) 1998-07-06 1999-06-28 Vacuna elaborada a partir de circovirus y parvovirus porcino.
UA2001020808A UA72891C2 (en) 1998-07-06 1999-06-28 Antigenic preparations comprising antigens of porcine circovirus and parvovirus and vaccines against porcine multisystemic wasting syndrome (pmws)
CA2332627A CA2332627C (fr) 1998-07-06 1999-06-28 Vaccin elabore a partir de circovirus et de parvovirus porcins
RU2001103135A RU2237492C2 (ru) 1998-07-06 1999-06-28 Иммуногенная композиция, вызывающая иммунный ответ против парвовируса и цирковируса свиньи, вакцина против многосистемного синдрома истощения свиней (pmws) (варианты), набор для вакцинации и способ ее осуществления
PT99932831T PT1094837E (pt) 1998-07-06 1999-06-28 Vacina de circovírus e parvovírus porcinos
EP99932831A EP1094837B1 (fr) 1998-07-06 1999-06-28 Vaccin elabore a partir de circovirus et de parvovirus porcins
DK99932831.3T DK1094837T3 (da) 1998-07-06 1999-06-28 Porcin circovirus og parvovirusvaccine
MXPA00012785A MXPA00012785A (es) 1998-07-06 1999-06-28 Vacuna de circovirus y parvovirus porcina.
CNB998091316A CN1168502C (zh) 1998-07-06 1999-06-28 猪环状病毒和细小病毒疫苗
PCT/EP1999/004698 WO2000001409A2 (fr) 1998-07-06 1999-06-28 Vaccin elabore a partir de circovirus et de parvovirus porcins
PL345948A PL205299B1 (pl) 1998-07-06 1999-06-28 Preparat antygenowy oraz szczepionka przeciwko zespołowi PMWS - poodsadzeniowemu wielonarządowemu zespołowi wyniszczającemu
DE69941843T DE69941843D1 (de) 1998-07-06 1999-06-28 Schweine-circovirus und -parvovirus impfstoff
US09/347,594 US6217883B1 (en) 1998-07-06 1999-07-01 Porcine circovirus and paravovirus vaccine
TW088111464A TWI221774B (en) 1998-07-06 2000-04-10 Porcine circovirus and parvovirus vaccine
US09/784,962 US6953581B2 (en) 1998-07-06 2001-02-16 Porcine circovirus and parvovirus vaccine
US10/653,849 US7192594B2 (en) 1997-10-03 2003-09-02 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US11/107,219 US20060029617A1 (en) 1997-10-03 2005-04-15 Porcine circovirus and Helicobacter combination vaccines and methods of use
US11/217,562 US7504206B2 (en) 1997-10-03 2005-09-01 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US11/485,240 US7833783B2 (en) 1997-10-03 2006-07-12 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US11/485,525 US7803613B2 (en) 1997-10-03 2006-07-12 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US11/522,237 US7803926B2 (en) 1997-10-03 2006-09-15 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
CY20101100181T CY1110290T1 (el) 1998-07-06 2010-02-25 Εμβολιο χοιρειου κυκλοϊου και κοκκοϊου
JP2010100018A JP2010222359A (ja) 1998-07-06 2010-04-23 ブタサーコウイルスおよびパルボウイルスワクチン

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808777A FR2781159B1 (fr) 1998-07-06 1998-07-06 Vaccin circovirus et parvovirus porcin

Publications (2)

Publication Number Publication Date
FR2781159A1 FR2781159A1 (fr) 2000-01-21
FR2781159B1 true FR2781159B1 (fr) 2000-10-06

Family

ID=9528441

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9808777A Expired - Lifetime FR2781159B1 (fr) 1997-10-03 1998-07-06 Vaccin circovirus et parvovirus porcin

Country Status (22)

Country Link
US (2) US6217883B1 (fr)
EP (1) EP1094837B1 (fr)
JP (2) JP4749547B2 (fr)
KR (1) KR100730336B1 (fr)
CN (1) CN1168502C (fr)
AT (1) ATE452653T1 (fr)
AU (1) AU746234B2 (fr)
BR (1) BRPI9911870B8 (fr)
CA (1) CA2332627C (fr)
CY (1) CY1110290T1 (fr)
DE (1) DE69941843D1 (fr)
DK (1) DK1094837T3 (fr)
ES (1) ES2338616T3 (fr)
FR (1) FR2781159B1 (fr)
HU (1) HU227805B1 (fr)
MX (1) MXPA00012785A (fr)
PL (1) PL205299B1 (fr)
PT (1) PT1094837E (fr)
RU (1) RU2237492C2 (fr)
TW (1) TWI221774B (fr)
UA (1) UA72891C2 (fr)
WO (1) WO2000001409A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049703A2 (fr) 2001-12-12 2003-06-19 Virginia Tech Intellectual Properties, Inc. Clones d'adn infectieux chimeres, circovirus porcins chimeres et utilisation de ceux-ci
RU2212898C1 (ru) * 2002-02-11 2003-09-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Штамм "вл-94" парвовируса свиней для изготовления вакцинных препаратов
WO2005092069A2 (fr) 2004-03-25 2005-10-06 Virginia Tech Intellectual Properties, Inc. Clones d'adn infectieux chimeriques, circovirus porcins chimeriques et utilisations de ceux-ci

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US7211379B2 (en) * 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US7192594B2 (en) * 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
DE07008633T1 (de) * 1997-12-11 2008-12-18 Merial Virus des multisystemischen Kümmersyndroms bei Absatzferkeln
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
DE10044648A1 (de) * 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
JP4038127B2 (ja) 2001-03-27 2008-01-23 ユニバーシティ オブ サスカチュワン サーコウイルスの培養方法
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
EP2390352A1 (fr) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systemes et procedes pour accroitre la production de proteines et de lait chez des bovins laitiers
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
US20040258700A1 (en) * 2003-06-23 2004-12-23 Frimann Tine Holland Vaccine formulation with a preservative
MXPA06005424A (es) 2003-11-13 2007-01-25 Univ Georgia Res Found Metodos para caracterizar virus de enfermedad bursal infecciosa.
CA2556911C (fr) 2004-02-19 2013-07-30 The Governors Of The University Of Alberta Polymorphismes du promoteur de la leptine et utilisations correspondantes
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
HUE025537T2 (en) * 2004-12-30 2016-05-30 Boehringer Ingelheim Vetmedica Inc PCV2-immunogenic compositions and methods for preparing such compositions
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
HRP20100314T1 (hr) 2005-04-25 2010-08-31 Merial Ltd. Cjepivo protiv nipah virusa
WO2006132598A1 (fr) * 2005-06-07 2006-12-14 Temasek Life Sciences Laboratory Limited Vaccins contre le circovirus porcin de type 2
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
KR100693077B1 (ko) * 2005-11-03 2007-03-12 채찬희 돼지 복합 호흡기 질환 예방 및 치료용 생물학적 조성물
EP3147296A1 (fr) 2005-11-14 2017-03-29 Merial, Inc. Thérapie génique pour traiter l'insuffisance rénale
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
HUE054868T2 (hu) * 2005-12-29 2021-10-28 Boehringer Ingelheim Animal Health Usa Inc Multivalens PVC2 immunogén készítmények és eljárások ezek elõállítására
EP1976558B1 (fr) 2005-12-29 2017-03-15 Boehringer Ingelheim Vetmedica, Inc. Composition immunogène de pcv2 pour la réduction de symptômes cliniques
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
US20100092512A1 (en) * 2006-10-05 2010-04-15 Ellis John A Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (fr) 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed Procede efficace de traitement du circovirus porcin et des infections par lawsonia intracellularis
ES2726777T3 (es) 2006-12-15 2019-10-09 Boehringer Ingelheim Animal Health Usa Inc Vacuna porcina anti-PCV2 en dosis única
EP1941903A1 (fr) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxie et traitement du PRDC
EP1958644A1 (fr) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prévention et traitement du PCVD subclinique
CN101294224B (zh) * 2007-05-08 2011-04-06 深圳太太基因工程有限公司 一种用于检测猪细小病毒核苷酸片段的引物和探针序列
WO2009029130A2 (fr) * 2007-05-30 2009-03-05 Wyeth Poxvirus de raton laveur exprimant des gènes d'un virus porcin
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
CL2008003813A1 (es) * 2007-12-21 2009-03-20 Zoetis W Llc Circovirus porcino; molecula de acido nucleico que lo codifica; composicion inmunogenica que lo comprende; metodo para inmunizar un cerdo contra la infeccion virica o para prevenir el sindrome postdestete de desgaste multi-sistemico (pmsw);y metodo para determinar si un mamifero tiene o esta en riesgo de desarrollar pmsw.
EP2231182A4 (fr) * 2007-12-31 2012-08-22 Boehringer Ingelheim Vetmed Particule de type virus pcv2 orf2 avec insertion d'acides aminés étrangers
WO2009126356A2 (fr) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Compositions immunogènes de mycoplasma hyopneumoniae pcv2, et procédés de production de telles compositions
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
CN102428099B (zh) 2009-04-03 2016-03-16 梅里亚有限公司 运载新城疫病毒的禽疫苗
TWI627281B (zh) * 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
MX344103B (es) 2010-08-31 2016-12-05 Merial Ltd Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle.
CN101947318B (zh) * 2010-09-09 2012-09-05 扬州优邦生物制药有限公司 一种猪细小病毒灭活疫苗的制备方法
TWI442935B (zh) 2010-12-22 2014-07-01 Sbc Virbac Ltd 豬第二型環狀病毒（Ｐｏｒｃｉｎｅ Ｃｉｒｃｏｖｉｒｕｓ Ｔｙｐｅ ２）、含彼之免疫組合物、檢測套組及其應用
WO2012090073A2 (fr) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Procédés et compositions pour prédire la sensibilité à la chimiothérapie
US20140296248A1 (en) 2011-04-04 2014-10-02 Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
US20140287931A1 (en) 2011-04-04 2014-09-25 Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
WO2012145577A1 (fr) 2011-04-20 2012-10-26 Merial Limited Vaccin antirabique avec adjuvant à profil de viscosité amélioré
EP2701736A1 (fr) 2011-04-25 2014-03-05 Advanced Bioscience Laboratories, Inc. Protéines tronquées d'enveloppe (env) du vih, procédés et compositions associés à celles-ci
CA2837375C (fr) 2011-06-01 2019-07-16 Merial Limited Administration sans aiguille de vaccins contre le vsrrp
EP2741740B1 (fr) 2011-08-12 2017-05-03 Merial, Inc. Procédé assistée par le vide pour la preservation des produits biologiques, notamment des vaccins
UA113192C2 (xx) * 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
WO2013093629A2 (fr) 2011-12-20 2013-06-27 Netherlands Cancer Institute Vaccins modulaires, procédés et compositions qui y sont liés
CN102961742A (zh) * 2012-01-13 2013-03-13 普莱柯生物工程股份有限公司 猪圆环病毒2型与猪细小病毒二联灭活疫苗及其制备方法
CN105749273A (zh) * 2012-01-13 2016-07-13 普莱柯生物工程股份有限公司 猪圆环病毒2型与猪细小病毒二联灭活疫苗及其制备方法
WO2013138776A1 (fr) 2012-03-16 2013-09-19 Merial Limited Nouveaux procédés pour fournir une immunité de protection à long terme contre la rage chez des animaux, basés sur l'administration d'un flavivirus défectueux en termes de réplication, exprimant la rage g
CN102719407B (zh) * 2012-05-25 2013-09-04 中国农业科学院哈尔滨兽医研究所 猪细小病毒bq-c株及其在制备猪细小病毒灭活疫苗中的应用
US9556419B2 (en) 2013-03-12 2017-01-31 Merial Inc. Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof
EP2994162B1 (fr) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccin pour pcv2 et mycoplasme
CA2925281C (fr) * 2013-09-25 2022-05-03 Zoetis Services Llc Composition vaccinale divergente anti-pcv2b et ses procedes d'utilisation
EP3052516B1 (fr) 2013-10-02 2020-01-01 Boehringer Ingelheim Animal Health USA Inc. Variant de protéine orf2 de pcv2 et particules de type viral composées de celui-ci
ES2771899T3 (es) * 2013-12-03 2020-07-07 Intervet Int Bv Vacuna contra circovirus porcino de tipo 2
CN104250640A (zh) 2014-08-22 2014-12-31 普莱柯生物工程股份有限公司 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
CA2966191A1 (fr) 2014-11-03 2016-05-12 Merial, Inc. Procedes d'utilisation de formulations de vaccin par micro-aiguilles pour eliciter une immunite de protection contre le virus de la rage chez les animaux
CN111560355A (zh) * 2015-03-20 2020-08-21 普莱柯生物工程股份有限公司 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用
WO2016183423A1 (fr) 2015-05-14 2016-11-17 Merial Inc. Procédé pour la production de vaccins contre le circovirus porcin et vaccins contre le pcv2
EP3889166B1 (fr) 2015-06-23 2025-08-06 Boehringer Ingelheim Vetmedica GmbH Vecteurs viraux recombinés contenant une protéine mineure de prrsv et leurs procédés de préparation et d'utilisation
BR112018069219A2 (pt) 2016-03-23 2019-01-22 Intervet Int Bv uma vacina para aplicação intradérmica contra infecção pelo vírus pcv2 e prrs
CN106435016B (zh) * 2016-08-30 2019-07-26 中国农业科学院兰州兽医研究所 一种快速显色一步法检测猪圆环病毒2型的lamp试剂盒
RS64144B1 (sr) * 2016-11-03 2023-05-31 Boehringer Ingelheim Vetmedica Gmbh Vakcina protiv svinjskog parvovirusa i virusa reproduktivnog i respiratornog sindroma svinja i postupci njegove proizvodnje

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1538305A1 (ru) 1987-07-21 1994-12-15 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
US5811103A (en) * 1989-03-19 1998-09-22 Akzo Nobel N.V. Hog cholera virus vaccine and diagnostic
ES2026827A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049703A2 (fr) 2001-12-12 2003-06-19 Virginia Tech Intellectual Properties, Inc. Clones d'adn infectieux chimeres, circovirus porcins chimeres et utilisation de ceux-ci
EP2264050A2 (fr) 2001-12-12 2010-12-22 Virginia Tech Intellectual Properties, Inc. Clones d'ADN infectieux chimeres de circovirus porcin et utilisation de ceux-ci
EP2263689A2 (fr) 2001-12-12 2010-12-22 Virginia Tech Intellectual Properties, Inc. Clones d'ADN infectieux chimeres de circovirus porcin et utilisation de ceux-ci
EP2263690A2 (fr) 2001-12-12 2010-12-22 Virginia Tech Intellectual Properties, Inc. Clones d'ADN infectieux chimeres de circovirus porcin et utilisation de ceux-ci
EP3388515A1 (fr) 2001-12-12 2018-10-17 Virginia Tech Intellectual Properties, Inc. Clones d'adn infectieux chimeres de circovirus porcin et utilisation de ceux-ci
RU2212898C1 (ru) * 2002-02-11 2003-09-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Штамм "вл-94" парвовируса свиней для изготовления вакцинных препаратов
WO2005092069A2 (fr) 2004-03-25 2005-10-06 Virginia Tech Intellectual Properties, Inc. Clones d'adn infectieux chimeriques, circovirus porcins chimeriques et utilisations de ceux-ci

Also Published As

Publication number Publication date
ES2338616T3 (es) 2010-05-10
CN1168502C (zh) 2004-09-29
KR100730336B1 (ko) 2007-06-19
WO2000001409A2 (fr) 2000-01-13
HUP0102770A3 (en) 2004-10-28
DK1094837T3 (da) 2010-04-12
PL205299B1 (pl) 2010-04-30
JP2010222359A (ja) 2010-10-07
EP1094837B1 (fr) 2009-12-23
BRPI9911870B8 (pt) 2015-09-22
WO2000001409A3 (fr) 2000-06-29
CA2332627C (fr) 2010-06-01
BR9911870A (pt) 2001-03-27
AU746234B2 (en) 2002-04-18
KR20010081991A (ko) 2001-08-29
FR2781159A1 (fr) 2000-01-21
HU227805B1 (en) 2012-03-28
AU4907799A (en) 2000-01-24
HUP0102770A2 (hu) 2001-11-28
US20020146431A1 (en) 2002-10-10
JP2003522106A (ja) 2003-07-22
PT1094837E (pt) 2010-03-18
DE69941843D1 (de) 2010-02-04
CN1311690A (zh) 2001-09-05
CY1110290T1 (el) 2015-01-14
TWI221774B (en) 2004-10-11
RU2237492C2 (ru) 2004-10-10
BR9911870B1 (pt) 2014-08-12
UA72891C2 (en) 2005-05-16
JP4749547B2 (ja) 2011-08-17
PL345948A1 (en) 2002-01-14
ATE452653T1 (de) 2010-01-15
CA2332627A1 (fr) 2000-01-13
US6217883B1 (en) 2001-04-17
EP1094837A2 (fr) 2001-05-02
MXPA00012785A (es) 2002-04-24
US6953581B2 (en) 2005-10-11

Similar Documents

Publication Publication Date Title
FR2781159B1 (fr) Vaccin circovirus et parvovirus porcin
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
EP1326633A4 (fr) Composition comprenant des microparticules immunogenes
PT2364724E (pt) Composição de vacina compreendendo um adjuvante de saponina
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
NO20015073L (no) Vaksiner
DE69939706D1 (de) Verbesserte adjuvant zusammensetzungen auf basis von saponin und damit zusammenhängende methoden
ES2149361T3 (es) Vacuna viva modificada contra el brsv, mejorada.
LU91326I2 (fr) Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé)
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
NO20023935D0 (no) Ny, ikke-antigen, mucosal adjuvantformulering som modulerer effektene av substanser, inkludert vaksineantigener, i kontakt medmucosale kroppsoverflater
DK0745387T3 (da) Adjuvanser til virale vacciner
ZA936629B (en) Potentiation of immunogenic response
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
DE60042816D1 (de) T-helferzellen-epitope
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
FR2769322B1 (fr) Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
BR9915703B1 (pt) mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
AR034771A1 (es) Formulacion vacunal potenciada por la combinacion de un adn con un antigeno
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
ECSP961731A (es) Vacunas
CY1116098T1 (el) Χιμαιρικοι μολυσματικοι κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20